François Roman

3.8k total citations
44 papers, 1.0k citations indexed

About

François Roman is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, François Roman has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 27 papers in Epidemiology and 17 papers in Virology. Recurrent topics in François Roman's work include Influenza Virus Research Studies (21 papers), HIV Research and Treatment (17 papers) and SARS-CoV-2 and COVID-19 Research (13 papers). François Roman is often cited by papers focused on Influenza Virus Research Studies (21 papers), HIV Research and Treatment (17 papers) and SARS-CoV-2 and COVID-19 Research (13 papers). François Roman collaborates with scholars based in Belgium, United States and United Kingdom. François Roman's co-authors include Paul Gillard, Mamadou Dramé, Emmanuel Hanon, Jeanne‐Marie Devaster, Geert Leroux‐Roels, Tino F. Schwarz, Pierre Van Damme, Markus Knuf, Cathy Maes and Fien De Boever and has published in prestigious journals such as Nature Communications, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

François Roman

43 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
François Roman Belgium 17 680 385 367 185 150 44 1.0k
W Keitel United States 18 744 1.1× 309 0.8× 318 0.9× 87 0.5× 265 1.8× 28 1.2k
John Treanor United States 8 790 1.2× 264 0.7× 290 0.8× 30 0.2× 120 0.8× 8 1.0k
Jin Hyang Kim United States 16 733 1.1× 233 0.6× 445 1.2× 28 0.2× 172 1.1× 35 1.1k
Ilaria Manini Italy 15 519 0.8× 188 0.5× 221 0.6× 54 0.3× 186 1.2× 37 759
Cecilia Chui United Kingdom 5 584 0.9× 246 0.6× 535 1.5× 87 0.5× 136 0.9× 6 925
Rajeev Dhere India 16 500 0.7× 339 0.9× 95 0.3× 75 0.4× 122 0.8× 60 868
Fabrice Bailleux France 14 628 0.9× 195 0.5× 139 0.4× 43 0.2× 62 0.4× 20 784
Susette Audet United States 24 1.4k 2.1× 624 1.6× 652 1.8× 110 0.6× 147 1.0× 38 2.0k
M L Clements United States 16 768 1.1× 294 0.8× 304 0.8× 161 0.9× 138 0.9× 18 978
Valérie Lorin France 18 289 0.4× 312 0.8× 399 1.1× 323 1.7× 171 1.1× 26 886

Countries citing papers authored by François Roman

Since Specialization
Citations

This map shows the geographic impact of François Roman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Roman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Roman more than expected).

Fields of papers citing papers by François Roman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Roman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Roman. The network helps show where François Roman may publish in the future.

Co-authorship network of co-authors of François Roman

This figure shows the co-authorship network connecting the top 25 collaborators of François Roman. A scholar is included among the top collaborators of François Roman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Roman. François Roman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paris, Robert, Dan Apter, Suresh B. Boppana, et al.. (2023). Incidence of Cytomegalovirus Primary and Secondary Infection in Adolescent Girls: Results From a Prospective Study. The Journal of Infectious Diseases. 228(11). 1491–1495. 4 indexed citations
2.
Gobeil, Philipe, Stéphane Pillet, Iohann Boulay, et al.. (2022). Durability and cross-reactivity of immune responses induced by a plant-based virus-like particle vaccine for COVID-19. Nature Communications. 13(1). 6905–6905. 7 indexed citations
3.
4.
Struck, Daniel, François Roman, Sébastien De Landtsheer, et al.. (2015). Near Full-Length Characterization and Population Dynamics of the Human Immunodeficiency Virus Type I Circulating Recombinant Form 42 (CRF42_BF) in Luxembourg. AIDS Research and Human Retroviruses. 31(5). 554–558. 11 indexed citations
5.
6.
Phillips, Andrew, Valentina Cambiano, Fumiyo Nakagawa, et al.. (2014). Potential Future Impact of a Partially Effective HIV Vaccine in a Southern African Setting. PLoS ONE. 9(9). e107214–e107214. 14 indexed citations
7.
Damme, Pierre Van, et al.. (2013). Long-term persistence of humoral and cellular immune responses induced by an AS03A-adjuvanted H1N1 2009 influenza vaccine. Human Vaccines & Immunotherapeutics. 9(7). 1512–1522. 9 indexed citations
8.
Saitoh, Akihiko, et al.. (2012). Safety and persistence of immunological response 6 months after intramuscular vaccination with an AS03-adjuvanted H1N1 2009 influenza vaccine. Human Vaccines & Immunotherapeutics. 8(6). 749–758. 9 indexed citations
9.
Gillard, Paul, Adrian Caplanusi, Markus Knuf, et al.. (2012). An assessment of prime‐boost vaccination schedules with AS03A‐adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults. Influenza and Other Respiratory Viruses. 7(1). 55–65. 28 indexed citations
10.
Yang, Pan‐Chyr, Chong‐Jen Yu, Shan‐Chwen Chang, et al.. (2012). Safety and immunogenicity of a split-virion AS03A-adjuvanted A/Indonesia/05/2005 (H5N1) vaccine in Taiwanese adults. Journal of the Formosan Medical Association. 111(6). 333–339. 8 indexed citations
11.
Durier, Christine, Corinne Desaint, F. Lucht, et al.. (2012). Long-term immunogenicity of two doses of 2009 A/H1N1v vaccine with and without AS03A adjuvant in HIV-1-infected adults. AIDS. 27(1). 87–93. 20 indexed citations
12.
Meulemeester, Marc De, Didier Giet, Giancarlo Icardi, et al.. (2011). Immunogenicity profile of a 3.75-Ug hemagglutinin pandemic rH5N1 split virion As03A-adjuvanted vaccine in elderly persons : a randomized trial. Open Repository and Bibliography (University of Liège). 3 indexed citations
13.
Meulemeester, Marc De, Didier Giet, Giancarlo Icardi, et al.. (2011). Immunogenicity Profile of a 3.75-μg Hemagglutinin Pandemic rH5N1 Split Virion AS03A-Adjuvanted Vaccine in Elderly Persons: A Randomized Trial. The Journal of Infectious Diseases. 203(8). 1054–1062. 27 indexed citations
14.
Roman, François, et al.. (2011). Rapid Immunization Against H5N1: A Randomized Trial Evaluating Homologous and Cross-Reactive Immune Responses to AS03A-Adjuvanted Vaccination in Adults. The Journal of Infectious Diseases. 204(4). 574–581. 18 indexed citations
15.
Launay, Odile, Corinne Desaint, Christine Durier, et al.. (2011). Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled Trial. The Journal of Infectious Diseases. 204(1). 124–134. 43 indexed citations
16.
17.
Ikematsu, Hideyuki, Hideaki Nagai, Masahiro Kawashima, et al.. (2010). Immunogenicity and safety of a novel AS03A-adjuvanted H1N1 2009 pandemic influenza vaccine in adults in Japan. Human Vaccines. 6(11). 888–893. 18 indexed citations
18.
Vijver, David van de, Ioanna Kousiappa, Claudia Balotta, et al.. (2010). Cellular HIV-1 DNA Levels in Drug Sensitive Strains Are Equivalent to Those in Drug Resistant Strains in Newly-Diagnosed Patients in Europe. PLoS ONE. 5(6). e10976–e10976. 11 indexed citations
19.
20.
Roman, François, Christine Lambert, Ana Vázquez, et al.. (2008). Impact on Replicative Fitness of the G48E Substitution in the Protease of HIV-1. JAIDS Journal of Acquired Immune Deficiency Syndromes. 48(3). 255–262. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by W Keitel Breakdown of academic impact, for papers by John Treanor Breakdown of academic impact, for papers by Jin Hyang Kim Breakdown of academic impact, for papers by Ilaria Manini Breakdown of academic impact, for papers by Cecilia Chui Breakdown of academic impact, for papers by Rajeev Dhere Breakdown of academic impact, for papers by Fabrice Bailleux Breakdown of academic impact, for papers by Susette Audet Breakdown of academic impact, for papers by M L Clements Breakdown of academic impact, for papers by Valérie Lorin
Rankless by CCL
2026